Kieren Marr

Financial relationships

  • Attribution: 
    Self
    Ineligible company: 
    MycoMed Technologies
    Topic: 
    fungal diagnostics
  • Attribution: 
    Self
    Ineligible company: 
    Cidara
    Topic: 
    Antifungals
  • Attribution: 
    Self
    Ineligible company: 
    Sfunga
    Topic: 
    Antifungals
Return to 2022 Infectious Disease Board Review Course